Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 46 results found. Search for [ astra zeneca vaccine trial ]

Results 1 to 21 of 46
BusinessToday.In
November 29, 2020
A 40-year-old Chennai-based man had alleged that he suffered serious side effects following vaccination and sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial


PTI
November 29, 2020
The legal notice has been sent to Pune based Serum Institute of India, which has collaborated with Oxford University and Astra Zeneca, a pharmaceutical company, in connection with making of the vaccine, 'Covidshield.'


PB Jayakumar
November 28, 2020
Prime Minister Narendra Modi's visit to these facilities and discussions with the scientists are to help him get a first-hand perspective of the preparations, challenges and roadmap in India's vaccination plans


Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


BusinessToday.In
November 13, 2020
Serum Institute has tied up with five developers that have made 40 million doses of the coronavirus vaccine in the past two months. They are aiming to start manufacturing of Novavax's candidate soon


PB Jayakumar
November 12, 2020
Covishield has been developed at the Serum Institute of India's Pune laboratory with a master seed from Oxford University/Astra Zeneca. The vaccine made in the UK is currently being tested in large efficacy trials in UK, Brazil, South Africa and USA


BusinessToday.In
November 12, 2020
Adar Poonawalla also spoke about what he thinks about vaccines that require ultra-cold storage. He said that it is \"a joke\" and will not work for developing nations


BusinessToday.In
November 12, 2020
Pfizer COVID-19 vaccine would need to be stored at -70 degree Celsius, which experts believe, would be a daunting challenge even for the best medical centres


BusinessToday.In
November 11, 2020
Coronavirus vaccine: India will focus on these two vaccines as they are being tested on the Indian population and hence has a major advantage over other potential candidates


Reuters
November 10, 2020
Enough people would be vaccinated by April-May, so that the fight against the pandemic in Spain would move to another stage


Reuters
November 10, 2020
Under Bingham's leadership, the taskforce has secured supply deals for more than 350 million doses of six different COVID-19 vaccine candidates, including the Pfizer shot


PTI
November 6, 2020
The World Economic Forum (WEF) said the latest survey has shown a growing reluctance to receive a vaccine, despite progress made by numerous pharmaceutical companies working on vaccine trials


BusinessToday.In
November 5, 2020
Coronavirus vaccine update: Data compiled by Duke Global Health Innovation Center said that India has pre-ordered 600 million doses of coronavirus vaccine and is now in the process of negotiation for additional 1 billion doses


BusinessToday.In
November 4, 2020
India has vaccine deals with Serum Institute of India that is manufacturing doses of the University of Oxford-AstraZeneca vaccine as well as the candidate by Novavax


Reuters
November 4, 2020
Coronavirus vaccine: \"I'm optimistic that we could reach that point before the end of this year,\" Andrew Pollard said of presenting trial results this year


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


PTI
November 1, 2020
Bharat Biotech Executive Director Sai Prasad said the price of the vaccine is yet to be determined, as the company is still looking at the cost of product development


BusinessToday.In
October 29, 2020
Coronavirus vaccine: PM Modi said that a digital platform is being created now that will eventually help in enrolling, tracking and reaching beneficiaries


BusinessToday.In
October 26, 2020
Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy


PAGES 1 OF 3  123